Amedeo's Top 20

Amedeo Smart

Independent Medical Education


21 June 2021

Multidisciplinary Journal Club

  1. Morse K, Kimizuka Y, Chan MPK, Shibata M, et al.
    Near-Infrared 1064 nm Laser Modulates Migratory Dendritic Cells To Augment the Immune Response to Intradermal Influenza Vaccine.
    J Immunol 2017.

  1. Yang J, Atkins KE, Feng L, Pang M, et al.
    Seasonal influenza vaccination in China: Landscape of diverse regional reimbursement policy, and budget impact analysis.
    Vaccine 2016.

  2. Chappell LC, Cluver CA, Kingdom J, Tong S, et al.
    Pre-eclampsia.
    Lancet 2021.

  3. Kovacs MJ, Wells PS, Anderson DR, Lazo-Langner A, et al.
    Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial.
    BMJ 2021;373:n1205.

  4. Shin GY, Park JM, Hong J, Cho YK, et al.
    Use of Proton Pump Inhibitors vs Histamine 2 Receptor Antagonists for the Risk of Gastric Cancer: Population-Based Cohort Study.
    Am J Gastroenterol 2021;116:1211-1219.

  1. Campbell Cree BA, Arnold DL, Chataway J, Chitnis T, et al.
    Secondary Progressive Multiple Sclerosis: New Insights.
    Neurology 2021.

  2. Feagan BG, Danese S, Loftus EV Jr, Vermeire S, et al.
    Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial.
    Lancet 2021.

  3. Tutt ANJ, Garber JE, Kaufman B, Viale G, et al.
    Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.
    N Engl J Med 2021.

  4. Jones WS, Mulder H, Wruck LM, Pencina MJ, et al.
    Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease.
    N Engl J Med 2021.

  5. Rolle CP, Berhe M, Singh T, Ortiz R, et al.
    Dolutegravir/lamivudine as a first-line regimen in a test-and-treat setting for newly diagnosed people living with HIV.
    AIDS 2021.

  1. Dackus GM, Jozwiak K, Sonke GS, van der Wall E, et al.
    Adjuvant Aromatase Inhibitors or Tamoxifen following Chemotherapy for Perimenopausal Breast Cancer Patients.
    J Natl Cancer Inst 2021.

  2. Ortega Exposito C, Falo C, Pernas S, Perez Carton S, et al.
    The effect of omitting axillary dissection and the impact of radiotherapy on patients with breast cancer sentinel node macrometastases: a cohort study following the ACOSOG Z0011 and AMAROS trials.
    Breast Cancer Res Treat 2021.

  3. Tolaney SM, Tayob N, Dang C, Yardley DA, et al.
    Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial.
    J Clin Oncol 2021.

  4. Bove F, Mulas D, Cavallieri F, Castrioto A, et al.
    Long-term Outcomes (15 Years) After Subthalamic Nucleus Deep Brain Stimulation in Patients With Parkinson Disease.
    Neurology 2021.

  5. Reynolds HR, Picard MH, Spertus JA, Peteiro J, et al.
    Natural History of Patients with Ischemia and No Obstructive Coronary Artery Disease: The CIAO-ISCHEMIA Study.
    Circulation 2021.

  1. He Y, Lu Y, Yang S, Li Y, et al.
    Dietary Plant Protein and Mortality Among Patients Receiving Maintenance Hemodialysis: A Cohort Study.
    Am J Kidney Dis 2021.

  2. Robson M.
    Management of Women With Breast Cancer and Pathogenic Variants in Genes Other Than BRCA1 or BRCA2.
    J Clin Oncol 2021.

  3. Mayer IA, Zhao F, Arteaga CL, Symmans WF, et al.
    Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131.
    J Clin Oncol 2021.

  4. van Lieshout JM, Mooij CF, van Trotsenburg ASP, Zwaveling-Soonawala N, et al.
    Methimazole-Induced Remission Rates in Pediatric Graves' Disease: a Systematic Review.
    Eur J Endocrinol 2021.

  5. Rivera-Lebron BN, Rali PM, Tapson VF.
    The PERT Concept: A Step-by-Step Approach to Managing Pulmonary Embolism.
    Chest 2021;159:347-355.


more..


Privacy Policy